Metabolizing Enzyme Polymorphisms and Prognosis Among Women Treated for Breast Cancer
Annual rept. 28 Sep 2001-27 Sep 2002
MINNESOTA UNIV MINNEAPOLIS
Pagination or Media Count:
This study will use archived tissue and data to examine survival of women treated for breast cancer in relation to inherited polymorphisms of drug metabolizing enzymes. During the first year of funding, we have completed compilation of tumor registry data for eligible subjects Task 1 of the approved statement of work. We have also completed study start-up tasks, including IRB review, hiring study staff, creating data collection forms, establishing a study database, and training study staff on data collection procedures. Collection of tissue samples Task 2 of the approved statement of work has begun. Activities currently in progress include obtaining pathology slides and blocks, review of slides by the study pathologist, and abstracting information from pathology reports into the study database. As described in the statement of work, data collection tasks will continue into years 2 and 3, so no reportable scientific results are available at the end of year 1.
- Anatomy and Physiology
- Medicine and Medical Research